Who we are
Key topics
Publications
Factsheets
Infographics
Reports
Policy
Videos
Podcast – Conversations on EU Pharma
Newsroom
Press releases
In the news
Press kit
JOB OPPORTUNITIES
Contact us
Login
Generic medicines
Home
Medicines for Europe
Generic medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
Definition
THERAPEUTIC AREAS
GLOSSARY
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Related links
Contact us
Twitter
Biosimilar medicines
Home
Medicines for Europe
Biosimilar medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
DEFINITION
THERAPEUTIC AREAS
GLOSSARY
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
External resources
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Related links
Contact us
Twitter
Value added medicines
Home
Who we are
Value added medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
Environment of value added medicines in Europe
Definition
THERAPEUTIC AREAS
Q&A
What’s new
Environment of value added medicines in Europe
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
Value Added Medicines award 2019
QUOTES
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Contact us
Events
#EGA20 – 26 June 2014 – Video Playlist
26 June 2014
The role of video in the patient recovery journey – Pablo Galiana:
At the Avant-Garde of Wearable Health – Sara Navarro Medina:
We All Are The New Media – Jaume Duch:
Moving forward the Participatory Medicine: A Conversation with Dr. Sergio Vañó:
Social is Healing: Accessing the Patients – Óscar Brihuega:
Let’s Patients Help! – Nuria Zúñiga:
Google Glass In Healthcare: The Next Big Thing – Rafael Grossmann:
Interactive conversation on Twitter about #EGA20:
“Connecting the Dots, Accessing Patients” Workshop at the EGA’s 20th Annual Conference
EGA Director General Take home message from 20th EGA Annual Conference
Related Posts
Billions more euros to re-invest in better healthcare thanks…
13 December 2022
Biosimilar medicines deliver access for patients suffering from serious and…
Essential medicines must be included in EU industrial policy…
3 March 2022
Political ambitions to strengthen EU supply chain resilience following the…
IQVIA Institute Scorecards show biosimilar medicines offer…
30 June 2020
Good biosimilar medicine policies balance the benefits of multi-source competition,…
European patients need improved access to biosimilar…
22 April 2021
Fifteen years after the first global approval, biosimilar medicines systemically…
Medicines For Europe
Who we are
WHO WE ARE – ABOUT MEDICINES FOR EUROPE
Purpose and Objectives
OUR VALUES
STRUCTURE
OUR MEMBERS
BECOME A MEMBER
CODE OF CONDUCT
DISCLOSURE
JOB OPPORTUNITIES
Key topics
COVID-19
Access
INDUSTRIAL POLICY
REGULATORY AND LEGAL FRAMEWORK
FALSIFIED MEDICINES
ENVIRONMENT
ANTIMICROBIAL RESISTANCE
MEDICINE SHORTAGES
Publications
Factsheets
Infographics
Reports
Policy
Videos
Podcast – Conversations on EU Pharma
Newsroom
Press releases
In the news
Press kit
Contact us
SECTOR GROUPS
Generic medicines
WHO WE ARE
DID YOU KNOW?
WHAT’S NEW
OUR 5 PILLARS
FIND OUT MORE
Biosimilar medicines
WHO WE ARE
DID YOU KNOW?
WHAT’S NEW
OUR 5 PILLARS
FIND OUT MORE
Value added medicines
WHO WE ARE
DID YOU KNOW?
WHAT’S NEW
OUR 5 PILLARS
Events
Tweet
Tweet
Tweet
LinkedIn